Home › IGA Glomerulonephritis › Utah
IGA Glomerulonephritis clinical trials in Utah
3 studies for IGA Glomerulonephritis are looking for participants at sites in Utah.
Cities in Utah
A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
- Utah Kidney Research Institute, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07773727Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Prim Childrens Hosp Inv Pharm, Salt Lake City
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 9, 2026 · NCT06994845Study of BHV-1400 in IgA Nephropathy
- Site-016, Salt Lake City
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.